Rubschlager family donates $2 million to AHA research

Paul and Joan Rubschlager, owners of Rubschlager Baking in Chicago, have donated $2 million to their family precision promise fund, which will support initiatives spearheaded by the American Heart Association (AHA).

The AHA Institute for Precision Cardiovascular Medicine is designed to target more effective treatment and prevention strategies for heart disease through studies that examine genetics, environments and lifestyle, according to an AHA press release.

The funding will offer research grants to the institute that will allow researchers and clinicians to access and study personal health information.

“The American Heart Association is so grateful for Paul and Joan’s support and leadership over the years. They are inspiring community leaders who understand the importance of research and the need to positively impact America’s No. 1 health threat—cardiovascular disease,” said Kevin Harker, executive vice president of the AHA’s Midwest Affiliate, in a statement. “We are eager to see the lifesaving impact from the precision medicine initiative on the treatment and prevention of heart disease and stroke.”

This isn’t the first donation the Rubschlagers have made. In 2014, they donated $1 million at the Chicago Heart Ball and were honored with the Heart of Gold Award.

“We hear about precision medicine at other medical research groups with which we are involved,” the Rubschlagers said in a statement. “Without a doubt, precision medicine is the foundation for future successful medical treatment. Treatment can be targeted to a specific condition for a specific individual, thus removing the need to experiment with treatments that may or may not succeed. We believe that this gift will allow AHA to get a running start with their precision medicine program.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."